IndraLab
Statements
Hydroxychloroquine inhibits SLC6A2. 2 / 2
|
2
reach
"Aspirin and hydroxychloroquine can reduce the NET‐triggered intrahepatic or lung metastatic capability of HCC by targeting cyclooxygenase‐2 or inhibiting upstream TLRs, particularly in combination with DNase I.
165
A recent clinical trial was conducted to see whether the anesthetic or analgesic approach employed during tumorectomy affected the development of NETosis, subsequent tumor recurrence and survival outcomes."